ClinicalThought

Share

Program Content

Activities

  • FAQs: PARPis in OC
    Pharmacists’ FAQs on the Use of PARP Inhibitors for Ovarian Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2021

    Expires: December 06, 2022

Faculty

cover img faculity

Colleen Bohnenkamp, PharmD, BCOP, BCPS

Oncology Clinical Pharmacist
The University of Kansas Health System
Kansas City, Kansas

cover img faculity

Dane Fritzsche, PharmD, BCOP

Clinical Instructor
Department of Pharmacy
University of Washington
Clinical Oncology Pharmacist
Pharmacy
Seattle Cancer Care Alliance/UW Medicine
Seattle, WA

Provided by

ProCE Banner

Supporters

AbbVie Inc.

GlaxoSmithKline

Partners

CSPE

ProCE Banner

National Association of Specialty Pharmacy

ProCE Banner